IGFBP2 and COVID-19: Given the association of lymphopenia with COVID-19 severity and higher mortality [51], particularly in moderate and severe cases, the negative correlation of IGFBP-2 with lymphocyte count in moderate COVID-19 may indicate its association with disease severity.